Published in Medicine and Law Weekly, May 19th, 2006
Study 1: Unrelated cord blood transplantation is an alternative for adults with hematological malignancies lacking an HLA-matched donor.
"We analyzed outcomes and risk factors after unrelated cord blood transplantation (CBT) in adults with hematologic malignancies. One hundred and seventy-one patients were transplanted after 1997. Their median age was 29 years (15-55), and the median follow-up time was 18 months (1-71)," scientists in France report
According to W. Arcese and colleagues at Hospital St. Louis in Paris, "Most patients had acute...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.